Publications by authors named "Mark A Dominick"

Claim this Profile
S
Strain-related differences in urine composition of male rats of potential relevance to urolithiasis.
Sarah H Tannehill-Gregg, Mark A Dominick, Amy J Reisinger, Jeffrey D Moehlenkamp, C Robbie Waites

Toxicol Pathol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary ammonium chloride for the acidification of mouse urine.
Amy J Reisinger, Sarah H Tannehill-Gregg, C Robbie Waites, Mark A Dominick, Beth E Schilling

J Am Assoc Lab Anim Sci· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist.
Crystal R Waites, Mark A Dominick, Thomas P Sanderson, Beth E Schilling

Toxicol Sci· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
William E Achanzar, Carolyn F Moyer, Laura T Marthaler, Russell Gullo, Shen-Jue Chen, Mark A Dominick

Toxicol Appl Pharmacol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar.
Sarah H Tannehill-Gregg, Thomas P Sanderson, Daniel Minnema, Richard Voelker, Borge Ulland, Mark A Dominick

Toxicol Sci· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subchronic urinary bladder effects of muraglitazar in male rats.
Terry R Van Vleet, M Randy White, Thomas P Sanderson, Samuel M Cohen, Martin Cano, Mark A Dominick

Toxicol Sci· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
Mark A Dominick, Melvin R White, Thomas P Sanderson, Terry Van Vleet, Samuel M Cohen

Toxicol Pathol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis